Literature DB >> 31239086

Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder.

Andrew A Herring1, Cody W Schultz2, Elaine Yang2, Mark K Greenwald3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31239086     DOI： 10.1016/j.ajem.2019.05.053

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  4 in total

1.  Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.

Authors:  Corey S Davis; Derek H Carr; Melody J Glenn; Elizabeth A Samuels
Journal:  Ann Emerg Med       Date:  2021-03-27       Impact factor: 6.762

2.  Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions.

Authors:  Timothy D Kelly; Kathryn F Hawk; Elizabeth A Samuels; Reuben J Strayer; Jason A Hoppe
Journal:  West J Emerg Med       Date:  2022-07-11

3.  In reply.

Authors:  Sarah M Bagley; Ziming Xuan; Michael Silverstein; Scott E Hadland; Alexander Y Walley
Journal:  Ann Emerg Med       Date:  2020-04       Impact factor: 5.721

4.  Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report.

Authors:  Laura M Szczesniak; Vincent J Calleo; Ross W Sullivan
Journal:  Harm Reduct J       Date:  2020-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.